GeoVax Labs, Inc.
GOVXNASDAQHealthcare● Active
$1.34
$-0.31(-18.79%)
Market Cap$1284348
P/E Ratio—
52W High$34.75
52W Low$0.963
GeoVax Labs, Inc. (GOVX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GOVX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$2.62
Est. -$1.60 · -63.8%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS
GOVX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 27, 2026 | -$2.16 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$1.60 | -$2.62 | -63.8% | — | — | — |
| ▲ Q2 FY2026 | Apr 2, 2026 | -$4.71 | -$2.29 | +51.4% | — | $0.00B | — |
| ▼ Q4 FY2025 | Nov 13, 2025 | -$6.00 | -$7.75 | -29.2% | — | — | — |
| ▲ Q3 FY2025 | Jul 28, 2025 | -$0.41 | -$0.35 | +14.6% | $0.00B | $0.00B | +9.8% |
| ▲ Q2 FY2025 | May 1, 2025 | -$0.59 | -$0.45 | +23.7% | $0.00B | $0.00B | +346.4% |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$0.79 | -$0.30 | +62.0% | $0.00B | $0.00B | -63.7% |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$1.29 | -$0.91 | +29.5% | $0.00B | $0.00B | +203.2% |
Q3 FY2026
Jul 27, 2026
EPS Actual
—
EPS Est.
-$2.16
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$2.62
EPS Est.
-$1.60
EPS Surpr.
-63.8%
Revenue
—
Q2 FY2026
Apr 2, 2026Beat
EPS Actual
-$2.29
EPS Est.
-$4.71
EPS Surpr.
+51.4%
Revenue
—
Q4 FY2025
Nov 13, 2025Miss
EPS Actual
-$7.75
EPS Est.
-$6.00
EPS Surpr.
-29.2%
Revenue
—
Q3 FY2025
Jul 28, 2025Beat
EPS Actual
-$0.35
EPS Est.
-$0.41
EPS Surpr.
+14.6%
Revenue
$0.00B
Q2 FY2025
May 1, 2025Beat
EPS Actual
-$0.45
EPS Est.
-$0.59
EPS Surpr.
+23.7%
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
-$0.30
EPS Est.
-$0.79
EPS Surpr.
+62.0%
Revenue
$0.00B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.91
EPS Est.
-$1.29
EPS Surpr.
+29.5%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q3 FY2028 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q2 FY2028 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q1 FY2028 | $-0.17 | $-0.17 | $-0.17 | 1 |
| Q4 FY2027 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Q3 FY2027 | $-0.18 | $-0.18 | $-0.18 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.5B | $0.5B | $0.5B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -63.8% | $1.30 | $1.26 | -3.08% |
| ▲ Q2 FY2026 | Apr 2, 2026 | +51.4% | $1.41 | $1.33 | -5.67% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -29.2% | $12.45 | $11.73 | -5.78% |
| ▲ Q3 FY2025 | Jul 28, 2025 | +14.6% | $19.75 | $18.50 | -6.33% |
| ▲ Q2 FY2025 | May 1, 2025 | +23.7% | $25.25 | $24.73 | -2.06% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +62.0% | $34.25 | $31.75 | -7.30% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +29.5% | $78.50 | $81.25 | +3.50% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +22.6% | $44.00 | $45.00 | +2.27% |
Q2 FY2026-3.08%
Report Date
May 14, 2026
EPS Beat/Miss
-63.8%
Price Before
$1.30
Price After
$1.26
Q2 FY2026-5.67%
Report Date
Apr 2, 2026
EPS Beat/Miss
+51.4%
Price Before
$1.41
Price After
$1.33
Q4 FY2025-5.78%
Report Date
Nov 13, 2025
EPS Beat/Miss
-29.2%
Price Before
$12.45
Price After
$11.73
Q3 FY2025-6.33%
Report Date
Jul 28, 2025
EPS Beat/Miss
+14.6%
Price Before
$19.75
Price After
$18.50
Q2 FY2025-2.06%
Report Date
May 1, 2025
EPS Beat/Miss
+23.7%
Price Before
$25.25
Price After
$24.73
Q1 FY2025-7.30%
Report Date
Mar 27, 2025
EPS Beat/Miss
+62.0%
Price Before
$34.25
Price After
$31.75
Q4 FY2024+3.50%
Report Date
Nov 12, 2024
EPS Beat/Miss
+29.5%
Price Before
$78.50
Price After
$81.25
Q3 FY2024+2.27%
Report Date
Aug 6, 2024
EPS Beat/Miss
+22.6%
Price Before
$44.00
Price After
$45.00
Avg Beat Reaction-2.60%
Avg Miss Reaction-4.43%
Beat Rate6 / 8 quarters
Largest Move-7.30% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GOVX ends December
GeoVax Labs, Inc. (GOVX) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-2.62 — missing the analyst consensus of $-1.60 by -63.8%. The next GOVX earnings date is expected around September 1, 2026.
Each quarter, investors track GOVX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GOVX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GOVX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GOVX earnings · 5 questionsGeoVax Labs, Inc.'s next earnings report is expected around September 1, 2026. GOVX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GOVX historically reports after market close (AMC).
GOVX earnings datewhen is GOVX earningsGOVX next earnings datewhen does GOVX report earningsGOVX earnings calendar
▸ Source: FMP · GeoVax Labs, Inc. SEC filings · US GAAP · GeoVax Labs, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026